BiotechTube

ChAdOx1-HBV + MVA-HBV + Nivolumab

Phase 2Active
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Chronic Hepatitis B

Conditions

Chronic Hepatitis B

Trial Timeline

Sep 21, 2022 → Oct 1, 2026

NCT ID
NCT05343481

About ChAdOx1-HBV + MVA-HBV + Nivolumab

ChAdOx1-HBV + MVA-HBV + Nivolumab is a phase 2 stage product being developed by Barinthus Biotherapeutics for Chronic Hepatitis B. The current trial status is active. This product is registered under clinical trial identifier NCT05343481. Target conditions include Chronic Hepatitis B.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT05343481Phase 2Active
NCT04778904Phase 1/2Completed

Competing Products

20 competing products in Chronic Hepatitis B

See all competitors
ProductCompanyStageHype Score
macitentan 10 mgBML, Inc.Phase 3
76
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
47
TERN-701Terns PharmaceuticalsPhase 1/2
38
Fludarabine + Cyclophosphamide + PRGN-3007PrecigenPhase 1
28
LY3556050 + PlaceboEli LillyPhase 2
52
THB001Third Harmonic BioPhase 1
25
BriquilimabJasper TherapeuticsPhase 1/2
33
BriquilimabJasper TherapeuticsPhase 1/2
33
BriquilimabJasper TherapeuticsPhase 2
44
Empagliflozin + Matching placeboEli LillyPhase 3
77
LY3461767 + PlaceboEli LillyPhase 1
33
Pirtobrutinib + Venetoclax + RituximabEli LillyPhase 3
77
LY3526318 + PlaceboEli LillyPhase 2
52
PirtobrutinibEli LillyPhase 2
52
Ibrutinib + LY3214996Eli LillyPhase 1
33
Pirtobrutinib + AcalabrutinibEli LillyPhase 2
52
LYR-210Lyra TherapeuticsPhase 2
44
LYR-220 Design 1 (Part 1 only) + LYR-220 Design 2 (Part 1 and Part 2) + Bilateral sham procedure control (Part 2)Lyra TherapeuticsPhase 2
44
480 Mometasone Furoate Sinus Drug DepotLyra TherapeuticsPhase 1
25
LYR-210 + Sham procedure controlLyra TherapeuticsPhase 3
69

Other Products from Barinthus Biotherapeutics

MVA-NP+M1 + SalinePhase 2
44
Seasonal influenza vaccine + MVA-NP+M1 + Sodium chloridePhase 2
44
MVA-NP+M1 + Saline + H3N2 (A/Belgium/2417/2015)Phase 2
44
ChAdOx1-MVA 5T4 vaccine + Nivolumab Infusion [Opdivo]Phase 1/2
33
ChAdOx1-HPV + MVA-HPV + PlaceboPhase 1/2
33